Cargando…

PIM1 promotes hepatic conversion by suppressing reprogramming-induced ferroptosis and cell cycle arrest

Protein kinase-mediated phosphorylation plays a critical role in many biological processes. However, the identification of key regulatory kinases is still a great challenge. Here, we develop a trans-omics-based method, central kinase inference, to predict potentially key kinases by integrating quant...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Yangyang, Wang, Chenwei, Zhuang, Xuran, Lin, Shaofeng, Luo, Miaomiao, Deng, Wankun, Zhou, Jiaqi, Liu, Lihui, Mao, Lina, Peng, Wenbo, Chen, Jian, Wang, Qiangsong, Shu, Yilai, Xue, Yu, Huang, Pengyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9448736/
https://www.ncbi.nlm.nih.gov/pubmed/36068222
http://dx.doi.org/10.1038/s41467-022-32976-9
_version_ 1784784131659399168
author Yuan, Yangyang
Wang, Chenwei
Zhuang, Xuran
Lin, Shaofeng
Luo, Miaomiao
Deng, Wankun
Zhou, Jiaqi
Liu, Lihui
Mao, Lina
Peng, Wenbo
Chen, Jian
Wang, Qiangsong
Shu, Yilai
Xue, Yu
Huang, Pengyu
author_facet Yuan, Yangyang
Wang, Chenwei
Zhuang, Xuran
Lin, Shaofeng
Luo, Miaomiao
Deng, Wankun
Zhou, Jiaqi
Liu, Lihui
Mao, Lina
Peng, Wenbo
Chen, Jian
Wang, Qiangsong
Shu, Yilai
Xue, Yu
Huang, Pengyu
author_sort Yuan, Yangyang
collection PubMed
description Protein kinase-mediated phosphorylation plays a critical role in many biological processes. However, the identification of key regulatory kinases is still a great challenge. Here, we develop a trans-omics-based method, central kinase inference, to predict potentially key kinases by integrating quantitative transcriptomic and phosphoproteomic data. Using known kinases associated with anti-cancer drug resistance, the accuracy of our method denoted by the area under the curve is 5.2% to 29.5% higher than Kinase-Substrate Enrichment Analysis. We further use this method to analyze trans-omic data in hepatocyte maturation and hepatic reprogramming of human dermal fibroblasts, uncovering 5 kinases as regulators in the two processes. Further experiments reveal that a serine/threonine kinase, PIM1, promotes hepatic conversion and protects human dermal fibroblasts from reprogramming-induced ferroptosis and cell cycle arrest. This study not only reveals new regulatory kinases, but also provides a helpful method that might be extended to predict central kinases involved in other biological processes.
format Online
Article
Text
id pubmed-9448736
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-94487362022-09-08 PIM1 promotes hepatic conversion by suppressing reprogramming-induced ferroptosis and cell cycle arrest Yuan, Yangyang Wang, Chenwei Zhuang, Xuran Lin, Shaofeng Luo, Miaomiao Deng, Wankun Zhou, Jiaqi Liu, Lihui Mao, Lina Peng, Wenbo Chen, Jian Wang, Qiangsong Shu, Yilai Xue, Yu Huang, Pengyu Nat Commun Article Protein kinase-mediated phosphorylation plays a critical role in many biological processes. However, the identification of key regulatory kinases is still a great challenge. Here, we develop a trans-omics-based method, central kinase inference, to predict potentially key kinases by integrating quantitative transcriptomic and phosphoproteomic data. Using known kinases associated with anti-cancer drug resistance, the accuracy of our method denoted by the area under the curve is 5.2% to 29.5% higher than Kinase-Substrate Enrichment Analysis. We further use this method to analyze trans-omic data in hepatocyte maturation and hepatic reprogramming of human dermal fibroblasts, uncovering 5 kinases as regulators in the two processes. Further experiments reveal that a serine/threonine kinase, PIM1, promotes hepatic conversion and protects human dermal fibroblasts from reprogramming-induced ferroptosis and cell cycle arrest. This study not only reveals new regulatory kinases, but also provides a helpful method that might be extended to predict central kinases involved in other biological processes. Nature Publishing Group UK 2022-09-06 /pmc/articles/PMC9448736/ /pubmed/36068222 http://dx.doi.org/10.1038/s41467-022-32976-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Yuan, Yangyang
Wang, Chenwei
Zhuang, Xuran
Lin, Shaofeng
Luo, Miaomiao
Deng, Wankun
Zhou, Jiaqi
Liu, Lihui
Mao, Lina
Peng, Wenbo
Chen, Jian
Wang, Qiangsong
Shu, Yilai
Xue, Yu
Huang, Pengyu
PIM1 promotes hepatic conversion by suppressing reprogramming-induced ferroptosis and cell cycle arrest
title PIM1 promotes hepatic conversion by suppressing reprogramming-induced ferroptosis and cell cycle arrest
title_full PIM1 promotes hepatic conversion by suppressing reprogramming-induced ferroptosis and cell cycle arrest
title_fullStr PIM1 promotes hepatic conversion by suppressing reprogramming-induced ferroptosis and cell cycle arrest
title_full_unstemmed PIM1 promotes hepatic conversion by suppressing reprogramming-induced ferroptosis and cell cycle arrest
title_short PIM1 promotes hepatic conversion by suppressing reprogramming-induced ferroptosis and cell cycle arrest
title_sort pim1 promotes hepatic conversion by suppressing reprogramming-induced ferroptosis and cell cycle arrest
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9448736/
https://www.ncbi.nlm.nih.gov/pubmed/36068222
http://dx.doi.org/10.1038/s41467-022-32976-9
work_keys_str_mv AT yuanyangyang pim1promoteshepaticconversionbysuppressingreprogramminginducedferroptosisandcellcyclearrest
AT wangchenwei pim1promoteshepaticconversionbysuppressingreprogramminginducedferroptosisandcellcyclearrest
AT zhuangxuran pim1promoteshepaticconversionbysuppressingreprogramminginducedferroptosisandcellcyclearrest
AT linshaofeng pim1promoteshepaticconversionbysuppressingreprogramminginducedferroptosisandcellcyclearrest
AT luomiaomiao pim1promoteshepaticconversionbysuppressingreprogramminginducedferroptosisandcellcyclearrest
AT dengwankun pim1promoteshepaticconversionbysuppressingreprogramminginducedferroptosisandcellcyclearrest
AT zhoujiaqi pim1promoteshepaticconversionbysuppressingreprogramminginducedferroptosisandcellcyclearrest
AT liulihui pim1promoteshepaticconversionbysuppressingreprogramminginducedferroptosisandcellcyclearrest
AT maolina pim1promoteshepaticconversionbysuppressingreprogramminginducedferroptosisandcellcyclearrest
AT pengwenbo pim1promoteshepaticconversionbysuppressingreprogramminginducedferroptosisandcellcyclearrest
AT chenjian pim1promoteshepaticconversionbysuppressingreprogramminginducedferroptosisandcellcyclearrest
AT wangqiangsong pim1promoteshepaticconversionbysuppressingreprogramminginducedferroptosisandcellcyclearrest
AT shuyilai pim1promoteshepaticconversionbysuppressingreprogramminginducedferroptosisandcellcyclearrest
AT xueyu pim1promoteshepaticconversionbysuppressingreprogramminginducedferroptosisandcellcyclearrest
AT huangpengyu pim1promoteshepaticconversionbysuppressingreprogramminginducedferroptosisandcellcyclearrest